This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information
Login or create an account to see restricted content
Login or RegisterOne of the main aims of treatment in T2D is to reduce the risk of vascular complications. Glucose control helps to reduce microvascular complications, but its impact on macrovascular outcomes remains uncertain. Patients with T2D may therefore require additional CV risk factor control.
This module outlines SGLT2 inhibitor CVOT data, safety informatio
Type 2 diabetes is a strong independent risk factor for cardiovascular